APA সাইটেশন

Evens, A. M., Carson, K. R., Kolesar, J., Nabhan, C., Helenowski, I., Islam, N., . . . Gordon, L. I. (2014). A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma. Ann Oncol.

শিকাগো স্টাইলে সাইটেশন

Evens, A. M., et al. "A Multicenter Phase II Study Incorporating High-dose Rituximab and Liposomal Doxorubicin Into the CODOX-M/IVAC Regimen for Untreated Burkitt's Lymphoma." Ann Oncol 2014.

এমএলএ সাইটেশন

Evens, A. M., et al. "A Multicenter Phase II Study Incorporating High-dose Rituximab and Liposomal Doxorubicin Into the CODOX-M/IVAC Regimen for Untreated Burkitt's Lymphoma." Ann Oncol 2014.